Immutep competitors

View the competitive landscape for Immutep, featuring companies like Novartis, Merck, and Bristol Myers Squibb. Mapping a different industry? Browse our competitor database or generate a competitor list for any company.

Immutep

Biotechnology company developing LAG-3 immunotherapies

List of Immutep competitors

Novartis

Multidivisional healthcare company researching immune checkpoint inhibitors for oncology
novartis.com
Merck

Biopharmaceutical company developing pembrolizumab combinations with LAG-3 targeted therapies
merck.com
Bristol Myers Squibb

Global pharmaceutical company producing first-to-market LAG-3 checkpoint inhibitors
bms.com
Incyte

Biopharmaceutical company developing immunotherapy inhibitors including LAG-3 clinical assets
incyte.com
Regeneron

Biotechnology company advancing clinical programs for LAG-3 antibody treatments
regeneron.com
MacroGenics

Clinical-stage biopharmaceutical company developing bispecific antibodies including LAG-3 targets
macrogenics.com

Track Immutep & Its Competitors

Follow their latest moves with a real-time news feed and summaries delivered straight to your inbox.

Browse competitors related to Immutep and other trending companies.